179 Inoperable stage 1 and stage 2 non-small cell lung cancer (NSCLC) treated with COVID-era 15 fraction hypo-fractionated radiotherapy: a single-centre retrospective analysis

Hatton, M. orcid.org/0000-0003-2778-7926, Mok, W.K., Das, T. et al. (7 more authors) (2025) 179 Inoperable stage 1 and stage 2 non-small cell lung cancer (NSCLC) treated with COVID-era 15 fraction hypo-fractionated radiotherapy: a single-centre retrospective analysis. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108288.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 Elsevier Inc.
Keywords: 32 Biomedical and Clinical Sciences; 3211 Oncology and Carcinogenesis; Lung; Cancer; Lung Cancer; Radiation Oncology; 6.5 Radiotherapy and other non-invasive therapies; Cancer
Dates:
  • Published (online): February 2025
  • Published: February 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jul 2025 09:37
Last Modified: 11 Jul 2025 09:38
Status: Published
Publisher: Elsevier BV
Identification Number: 10.1016/j.lungcan.2025.108288
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)